Global Health Ltd. (MEDANTA) Share Price Hits Fresh 52-Week High
- August 3, 2026
- Posted by: Harsh Piplani
- Category: News
Global Health Ltd. Share Price reached a fresh 52-week high of Rs 1,465, rising 4.02% today. The market cap stands at Rs 37,867.9 crore.
Global Health Ltd. Share Price surged to a new 52-week high today, closing at Rs 1,465, marking a 4.02% increase from the previous close of Rs 1,408.4. The stock opened at Rs 1,402.4 and reached an intraday high of Rs 1,475.75, with a market capitalisation of Rs 37,867.9 crore. This significant price movement places the company in the spotlight, drawing attention from investors and analysts alike. The fresh 52-week high underscores the stock’s recent momentum, although the data does not specify a company-specific catalyst for this rise.
Global Health Ltd. Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,465 |
| Previous Close | Rs 1,408.4 |
| Today's Change | +Rs 56.6 (+4.02%) |
| Day Open | Rs 1,402.4 |
| Fresh 52-Week High | Rs 1,475.75 |
| Day Low | Rs 1,402.4 |
| Current Volume | 20,664 |
| Turnover | Rs 3.03 crore |
| Market Capitalisation | Rs 37,867.9 crore |
Global Health Ltd. (MEDANTA) traded at Rs 1,465. versus the previous close of Rs 1,408.4, a rise of 4.02%. The stock opened at Rs 1,402.4, reached Rs 1,475.75, touched Rs 1,402.4. Reported volume was 20,664.
Today, Global Health Ltd. Share Price opened at Rs 1,402.4 and quickly gained traction, reaching a high of Rs 1,475.75 before settling at Rs 1,465. This represents a 4.02% increase from the previous close of Rs 1,408.4. The stock’s turnover was Rs 3.03 crore, with a trading volume of 20,664 shares, indicating robust market participation. The fresh 52-week high of Rs 1,475.75 highlights the stock’s upward trajectory, suggesting strong investor interest. This price action sets the stage for further analysis of the company’s fundamentals and sector positioning.
Global Health Ltd. (MEDANTA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 37,867.9 crore |
| P/E Ratio | 30.09x |
| P/B Ratio | 0.44x |
| ROE | -2.89% |
| ROCE | -0.26% |
Global Health Ltd. was valued at a P/E ratio of 30.09x, a P/B ratio of 0.44x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -2.89% and ROCE of -0.26%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 30.09x |
| Benchmark Median P/E | 20.73x |
| Benchmark Average P/E | 67.98x |
| Benchmark P/E Range | 0x to 3,417.8x |
| Company P/B Ratio | 0.44x |
| Benchmark Median P/B | 1.91x |
| Company ROE | -2.89% |
| Benchmark Median ROE | 10.7% |
| Company ROCE | -0.26% |
| Benchmark Median ROCE | 13.13% |
| Company Market Capitalisation | Rs 37,867.9 crore |
| Benchmark Median Market Cap | Rs 130.49 crore |
Global Health Ltd. (MEDANTA) is classified under sector: Healthcare.
Global Health Ltd. (MEDANTA) has a P/E ratio of 30.09x, which is above the benchmark median of 20.73x, a difference of +45.15%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Global Health Ltd. (MEDANTA) has a ROE of -2.89%, which is below the benchmark median of 10.7%, a difference of -127.01%. Global Health Ltd. (MEDANTA) has a ROCE of -0.26%, which is below the benchmark median of 13.13%, a difference of -101.98%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Dishman Carbogen Amcis Ltd. | DCAL | 2,931.84 | 30.09 | 0.44 | -2.89 | -0.26 |
| Kwality Pharmaceuticals Ltd. | KPL | 2,683.28 | 39.84 | 8.11 | 28.21 | 26.35 |
| Beta Drugs Ltd. | BETA | 2,474.26 | 59.65 | 7.97 | 18.65 | 22.17 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,416.82 | 169.49 | 3.13 | 13.9 | 12.97 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,414 | 34.44 | 6.97 | -2.6 | 16.92 |
Global Health Ltd. (MEDANTA) has a P/E ratio of 30.09x compared with the displayed peer median of 39.84x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -2.89% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at -0.26% versus the displayed peer median of 16.92%, providing a capital-efficiency comparison. Global Health Ltd. (MEDANTA) has a market capitalisation of Rs 37,867.9 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching Global Health Ltd.
- Global Health Ltd. Share Price reached a fresh 52-week high, indicating strong market interest.
- The stock’s P/E ratio is moderate compared to sector benchmarks.
- Market cap significantly exceeds that of several peers, highlighting its market position.
- Sector analysis shows potential undervaluation based on P/B ratio.
About Global Health Ltd.
Global Health Ltd., operating under the symbol MEDANTA, is a prominent player in the healthcare sector. The company is involved in providing a range of healthcare services and operates several hospitals across India. With a focus on delivering high-quality medical care, Global Health Ltd. has established itself as a key player in the industry. The company’s operations span various medical specialties, contributing to its comprehensive healthcare offerings and market presence.
Track Global Health Ltd. Share Price on Univest
Use Global Health Ltd. (MEDANTA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors can track Global Health Ltd. Share Price, technical indicators, fundamental ratios, shareholding pattern, 52-week levels, and market insights on Univest. Stay informed with real-time data and analysis to make well-informed investment decisions.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the current share price of Global Health Ltd.?
Ans. The current share price of Global Health Ltd. is Rs 1,465, marking a 4.02% increase from the previous close of Rs 1,408.4, reaching a fresh 52-week high. The stock moved 4.02% during the session.
How does Global Health Ltd.'s P/E ratio compare to the sector?
Ans. Global Health Ltd.'s P/E ratio of 30.09 is above the sector median of 20.73 but below the average of 67.98, indicating a moderate valuation. The company trades at a P/E ratio of 30.09x.
What is the market capitalisation of Global Health Ltd.?
Ans. Global Health Ltd. has a market capitalisation of Rs 37,867.9 crore, significantly higher than many of its sector peers. The company operates in the Healthcare sector. Its P/E ratio is 30.09x.
How does Global Health Ltd.'s ROE compare to its peers?
Ans. Global Health Ltd.'s ROE of -2.89% is lower than its peers, indicating challenges in generating returns on equity compared to other companies. ROE stands at -2.89%. ROCE stands at -0.26%.
What is the significance of the fresh 52-week high for Global Health Ltd.?
Ans. The fresh 52-week high of Rs 1,475.75 highlights strong investor interest and positive market momentum for Global Health Ltd. The stock moved 4.02% during the session. The intraday range extended from Rs 1,402.4 to Rs 1,475.75.
How does Global Health Ltd.'s P/B ratio compare to the sector?
Ans. Global Health Ltd.'s P/B ratio of 0.44 is significantly lower than the sector median of 1.91, suggesting potential undervaluation. The company trades at a P/E ratio of 30.09x. Its P/B ratio is 0.44x.
How does Global Health Ltd.'s market cap compare to its peers?
Ans. Global Health Ltd.'s market cap of Rs 37,867.9 crore is significantly higher than its peers, highlighting its strong market position. The company operates in the Healthcare sector. Its P/E ratio is 30.09x.
